Skip to content

SHOE-OFF

SHOE-OFF: These shoes are made for offloading - SHOE-OFF

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58466
Enrollment
640
Registered
2026-03-12
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes, loss of sensation loss of sensation

Interventions

The SHOE-OFF protocol: structured, protocolized, quantified, evidence-based, and documentable assistive device care, providing as much offloading as necessary to heal and prevent ulcers, while priorit

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Neuropathy and a ulcer on the plantar side of the foot. 

Exclusion criteria

Exclusion criteria: None. 

Design outcomes

Primary

MeasureTime frame
Quality of life, measured using the EQ-5D-5L and expressed in quality-adjusted life years (QALYs). This outcome measure was chosen because it best captures both clinical effects and the patient perspective, because it is part of the Core Outcome Set for research on diabetic foot ulcers, because the study is conducted in a population where quality of life is significantly reduced when a foot ulcer is present, and because it facilitates comparison with other studies. Hospitals will collect this data as part of standard care at their centers, as part of the PROMs determined in standard care.In addition, the other endpoints from the Core Outcome Set will be collected, as they are all part of routinely recording healthcare outcomes in the patient record: time to healing, foot infection, foot or leg amputation, ulcer recurrence, and mortality.

Secondary

MeasureTime frame
Costeffectiveness,  percentage ulcer healing at 12 and 52 weeks, time to ulcer healing, ulcer recurrence, ulcer-free survival days, physical activity, amputations, infections, mortality, satisfaction with the protocol, adverse events (i.e. falls and pre-ulcer lesions). 

Countries

Netherlands

Contacts

Public ContactJ. van Netten

Amsterdam UMC

j.j.vannetten@amsterdamumc.nl020-5664421

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Apr 3, 2026